AstraZeneca and Celgene collaborate to develop MEDI4736 for patients with serious blood cancers
24 April 2015 | By Victoria White
AstraZeneca and Celgene collaborate for the development and commercialisation of MEDI4736 across a range of blood cancers, including non-Hodgkin’s lymphoma...